Cosmos Health Inc. (COSM) stock
COSMNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 18, 2026Score 4/30107% above fair value
$2.85+0.36 (+14.46%)
Close on Nov 17, 2026Market cap $286.81MP/E –Yield –
Cosmos Health total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Cosmos Health's total debt was $1.16M at Jun 30, 2026. For fiscal 2025 it was $1.58M, up 1.5% from the year before. The highest annual figure on record is $12.72M in fiscal 2021.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.58M | +1.5% |
| FY2024 | Dec 31, 2024 | $1.56M | -68.4% |
| FY2023 | Dec 31, 2023 | $4.94M | +72.9% |
| FY2022 | Dec 31, 2022 | $2.86M | -77.5% |
| FY2021 | Dec 31, 2021 | $12.72M | +18.1% |
| FY2020 | Dec 31, 2020 | $10.77M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.16M | -43.7% |
| Q1 FY2026 | Mar 31, 2026 | $1.34M | -35.9% |
| Q4 FY2025 | Dec 31, 2025 | $1.58M | +1.5% |
| Q3 FY2025 | Sep 30, 2025 | $1.80M | -32.1% |
| Q2 FY2025 | Jun 30, 2025 | $2.05M | -14.1% |
| Q1 FY2025 | Mar 31, 2025 | $2.09M | -26.3% |
| Q4 FY2024 | Dec 31, 2024 | $1.56M | -68.4% |
| Q3 FY2024 | Sep 30, 2024 | $2.65M | -16.3% |
| Q2 FY2024 | Jun 30, 2024 | $2.39M | -5.0% |
| Q1 FY2024 | Mar 31, 2024 | $2.83M | +3.9% |
| Q4 FY2023 | Dec 31, 2023 | $4.94M | +72.9% |
| Q3 FY2023 | Sep 30, 2023 | $3.16M | +1044.1% |
| Q2 FY2023 | Jun 30, 2023 | $2.52M | +698.4% |
| Q1 FY2023 | Mar 31, 2023 | $2.73M | -60.4% |
| Q4 FY2022 | Dec 31, 2022 | $2.86M | -77.5% |
| Q3 FY2022 | Sep 30, 2022 | $276.23K | -97.4% |
| Q2 FY2022 | Jun 30, 2022 | $315.30K | – |
| Q1 FY2022 | Mar 31, 2022 | $6.89M | – |
| Q4 FY2021 | Dec 31, 2021 | $12.72M | – |
| Q4 FY2020 | Dec 31, 2020 | $10.77M | – |
See a number that looks wrong?